other material
confidence high
sentiment neutral
materiality 0.80
Zura Bio prices $125M public offering of 18.2M shares at $6.25 and 1.8M pre-funded warrants
Zura Bio Ltd
- Offering: 18.2M Class A ordinary shares at $6.25/share, plus 1.8M pre-funded warrants at $6.249 each.
- Net proceeds expected ~$134.6M; underwriters' option for 3M additional shares exercised in full.
- Preliminary cash and equivalents as of Dec 31, 2025: ~$109.4M.
- Total outstanding ordinary shares after offering (excl. pre-funded warrants) ~94.9M.
- Offering expected to close Feb 26, 2026; joint bookrunners: Leerink, Piper Sandler, Cantor.